4/A: Twist Bioscience CFO Sells Shares to Cover Tax Obligations

Twist Bioscience's Chief Financial Officer, Adam Laponis, sold 4,160 shares of common stock to cover tax obligations related to vesting Performance Stock Units.

Summary

• Adam Laponis, the Chief Financial Officer of Twist Bioscience, sold 4,160 shares of common stock on November 6, 2024.
• The sale was executed at a price of $44.605 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of Performance Stock Units (PSUs).
• The sale was not a discretionary trade by Mr. Laponis but was mandated by the company's equity incentive plan.
• This amended filing corrects a footnote from the original Form 4 filed on November 8, 2024.

Sentiment

Score: 6

Explanation: The document describes a routine transaction related to executive compensation and tax obligations. It is not indicative of any positive or negative sentiment towards the company's performance.

Industry Context

This type of transaction is common for executives who receive equity compensation, as they often need to sell shares to cover the associated tax liabilities.

Comparison to Industry Standards

• Many companies use 'sell to cover' mechanisms for equity compensation to simplify tax obligations for employees.
• This type of transaction is standard practice across the industry for executives receiving stock-based compensation.
• The sale of shares to cover taxes is a common occurrence and does not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Twist Bioscience, Adam Laponis, CFO, stock sale, tax obligations, Performance Stock Units, equity incentive plan, Form 4